4 studies found for:    15057920 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR
Condition: Chronic Hepatitis C
Interventions: Drug: Peg-IFN + WB RBV for 16 weeks;   Drug: Peg-IFN + LD RBV for 16 weeks;   Drug: Peg-IFN + WB RBV for 24 weeks;   Drug: Peg-IFN + WB RBV for 48 weeks;   Drug: Peg-IFN + LD RBV for 24 weeks
2 Unknown  Early Prediction of Successful Treatment for Chronic Hepatitis C Virus Infection in Taiwan
Condition: Chronic Hepatitis C
Intervention: Drug: Pegylated interferon alfa and ribavirin
3 Unknown  Four Arms, Multicenter Study of Tailored Regimens With Peginterferon Plus Ribavirin for Genotype 2 Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: pegylated interferon alpha 2a and plus ribavirin;   Drug: Pegylated interferon alfa-2a and ribavirin;   Drug: pegylated interferon alpha 2a and ribavirin
4 Completed A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 Patients
Conditions: Chronic Hepatitis C;   Genotype
Interventions: Drug: pegylated interferon alpha 2a and ribavirin;   Drug: Pegylated interferon alfa-2a and ribavirin

Indicates status has not been verified in more than two years